Capital Bank & Trust’s Labcorp LH Stock Holding History

Capital Bank & Trust’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-17	Closed	-$3K	–	779
2019 Q3	$3K	Buy	+17	New	+$2.48K	﹤0.01%	674
2019 Q2	–	Sell	-41	Closed	-$5K	–	707
2019 Q1	$5K	Buy	+41	New	+$5.05K	﹤0.01%	597

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Bank & Trust's LH Position: Q4 2019 in Review

Capital Bank & Trust sold out of Labcorp (LH) in Q4 2019, closing a stake of 17 shares — an estimated $3K sold.

Capital Bank & Trust first reported a position in LH in Q1 2019 and held it in 2 quarters. The position peaked at $5K in Q1 2019. 802 funds tracked by Wall St. Rank hold LH as of Q4 2019.

Capital Bank & Trust reported no remaining Labcorp position as of Q4 2019 after selling out during the quarter.
Capital Bank & Trust sold 17 Labcorp shares in Q4 2019, an estimated $3K.
Capital Bank & Trust first reported a position in Labcorp in Q1 2019 and held it in 2 quarters.
Capital Bank & Trust's Labcorp position peaked at $5K in Q1 2019.
802 funds tracked by Wall St. Rank held Labcorp as of Q4 2019.

Based on Capital Bank & Trust's 13F filing for Q4 2019, filed 18 Feb 2020.